Type6
Transformative medicines against kinase-addicted diseases.
Novato, United States · Founded 2019 · $3.7M raised
- Headquarters
- Novato, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Total Funding
- $3.7M
- Last Round
- $3.7M Seed
- Rounds
- 1
About
Founded in 2019, Type6 Therapeutics pioneers OFF-state kinase inhibition using computational biology, multivalent chemistry, and allostery-aware drug design. Its lead CDK2 program shows 100x greater selectivity than competing inhibitors and a dual mechanism of potent inhibition plus targeted degradation, targeting aggressive cancers with p53 or MYC alterations.
Summary
Type6 is a SaaS company based in Novato, United States, founded in 2019. It has raised $3.7M in total across 1 round. Investors include Reinforced Ventures.
Funding History
Unknown
Investors
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
Economic infrastructure for the internet.
Food and facilities management services
Visma is a European provider of mission-critical enterprise resource planning software and servic...
For more than 30 years, BMC has helped thousands of companies around the world master IT complexi...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/type6"><img src="https://indexed.vc/api/badge/company/type6" alt="Type6 on Indexed.vc" width="260" height="76" /></a>